A Vietnam Launch Date That Fell a Month Ahead of the Apostille Clock

In August 2026, the Korean manufacturing subsidiary of a U.S. medical device company was preparing to register a product in Vietnam. The regulatory team assumed an apostille on the Certificate of Free Sale (CFS) and Letter of Authorization (LOA) would be enough — but the effective date turned out to be the problem. Even though Vietnam had completed its accession to the Apostille Convention, the Convention wouldn't actually enter into force there until September 11. Until then, the receiving authority still required translation, notarization, Ministry of Foreign Affairs confirmation, and Vietnamese embassy legalization. Sending the documents through the wrong channel risked delaying both the registration review and the distribution agreement behind it. Booking each authority separately would have been difficult too, with the product launch date already close. Apostille Korea first confirmed the submission date against the receiving authority's current checklist. They checked the seals and English notation on the MFDS documents, then managed translation, notarization, Ministry of Foreign Affairs confirmation, and Vietnamese embassy legalization as one continuous process. The finished documents were delivered in time for the registration schedule, and the local review began as planned. The U.S. headquarters didn't have to move its launch date or its distribution agreement timeline either. The regulatory lead said what stood out was being told about the regulatory change in advance, with clear updates at every step. Apostille Korea's expertise was in catching the small gap between the newest rule and the actual submission date — and not letting it slip through.